earnings
SA
NASDAQ · SABS
SAB Biotherapeutics, Inc.
Healthcare · Biotechnology
$3.78
Up+$0.08 (+2.16%)
Updated Aug 22, 2026, 1:51 PM
SID Score
4.0/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 34.31M
- P/E ratio
- 2.04
- Dividend yield
- 0.00%
- 52-week range
- $3.28 – $5.15
- Volume
- 195.67K
- Avg. volume
- 331K
Price performance
SABS price history
1M range · 21 trading sessions · Daily adjusted prices
SABS closed at $3.78 after 21 trading sessions, up 7.69% for the selected period.
- Last close
- $3.78
- Period change
- +7.69%
- Period low
- $3.44
- Period high
- $3.90
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 21, 2026 | $3.74 | $3.83 | $3.70 | $3.78 | 195.67K |
| Aug 20, 2026 | $3.75 | $3.7607 | $3.66 | $3.70 | 229.63K |
| Aug 19, 2026 | $3.83 | $3.88 | $3.76 | $3.78 | 701.27K |
| Aug 18, 2026 | $3.75 | $3.82 | $3.67 | $3.79 | 351.3K |
| Aug 17, 2026 | $3.70 | $3.85 | $3.69 | $3.77 | 232.03K |
| Aug 14, 2026 | $3.77 | $3.78 | $3.6801 | $3.70 | 324.66K |
| Aug 13, 2026 | $3.82 | $3.84 | $3.74 | $3.75 | 256.87K |
| Aug 12, 2026 | $3.76 | $3.83 | $3.70 | $3.80 | 307.68K |
| Aug 11, 2026 | $3.79 | $3.7934 | $3.67 | $3.76 | 312.04K |
| Aug 10, 2026 | $3.89 | $3.89 | $3.755 | $3.78 | 297.36K |
| Aug 7, 2026 | $3.86 | $3.95 | $3.85 | $3.90 | 343.91K |
| Aug 6, 2026 | $3.76 | $3.87 | $3.61 | $3.85 | 280.36K |
| Aug 5, 2026 | $3.86 | $3.8938 | $3.72 | $3.77 | 284.31K |
| Aug 4, 2026 | $3.80 | $3.97 | $3.73 | $3.85 | 1.16M |
| Aug 3, 2026 | $3.59 | $3.855 | $3.505 | $3.79 | 676.23K |
| Jul 31, 2026 | $3.56 | $3.58 | $3.42 | $3.57 | 405.03K |
| Jul 30, 2026 | $3.49 | $3.59 | $3.464 | $3.56 | 208.64K |
| Jul 29, 2026 | $3.43 | $3.545 | $3.395 | $3.48 | 371.5K |
| Jul 28, 2026 | $3.40 | $3.49 | $3.35 | $3.45 | 241.31K |
| Jul 27, 2026 | $3.53 | $3.635 | $3.43 | $3.44 | 609.58K |
| Jul 24, 2026 | $3.59 | $3.615 | $3.47 | $3.51 | 954.27K |
Latest SABS news
The latest Smart Investors Daily articles mentioning SABS.
Stock researchResearch & News · Competitors
Loading stock research…

